banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Tirzepatide CAS 2023788-19-2

Tirzepatide CAS 2023788-19-2

CAS Nr: 2023788-19-2
Cov mis mos molecular: C225H348N48O68
Molecular Luj: 4813.45
EINECS NO:200-001-8
MDL NO.: N/A

Txhawb tshuaj

Product Description:

Khoom npe: Tirzepatide CAS 2023788-19-2

 

Synonyms:

GIP\GLP-1;

Gip\GLP-1 Tirzepatide Ly3298176 Peptide.

 

Chemical & Physical Properties

Qhov tsos: dawb hmoov

Kev Ntsuas: NLT98%

Solubility: Soluble hauv DMSO

 

Daim Ntawv Thov: Tirzepatide muaj qhov sib npaug zoo sib xws rau semaglutide. Lub lys sab saw nyob rau hauv ib ntu yog hloov kho nrog PEG, uas yog ib pawg ua haujlwm ntawm polypeptide thiab tuaj yeem ua rau kom cov dej solubility ntawm qhov sib lawv liag.Lub ntsiab physiological muaj nuj nqi ntawm Tirzepa Chemicalbooktide yog ib tug dual agonist ntawm qabzib-dependent insulinotropic polypeptide (GIP) thiab glucagon-zoo li peptide-1 (GLP-1) receptors. Nws yog tsim los rau kev kho mob ntshav qab zib hom 2 thiab tau nkag mus rau theem kho mob.

 

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

 

Cov khoom raws li patent yog muab rau R & D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tsuas yog nrog tus neeg yuav khoom.

Cim npe nrov: tirzepatide cas 2023788-19-2, tuam ntxhab, lwm tus muag khoom, Hoobkas, yuav, hauv Tshuag

Xa kev nug